BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 34835958)

  • 1. The Role of Short-Chain Fatty Acids in Mediating Very Low-Calorie Ketogenic Diet-Infant Gut Microbiota Relationships and Its Therapeutic Potential in Obesity.
    Alsharairi NA
    Nutrients; 2021 Oct; 13(11):. PubMed ID: 34835958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Short-Chain Fatty Acids in the Interplay between a Very Low-Calorie Ketogenic Diet and the Infant Gut Microbiota and Its Therapeutic Implications for Reducing Asthma.
    Alsharairi NA
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Therapeutic Role of Short-Chain Fatty Acids Mediated Very Low-Calorie Ketogenic Diet-Gut Microbiota Relationships in Paediatric Inflammatory Bowel Diseases.
    Alsharairi NA
    Nutrients; 2022 Oct; 14(19):. PubMed ID: 36235765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Synbiotic Supplementation in a Very-Low-Calorie Ketogenic Diet on Weight Loss Achievement and Gut Microbiota: A Randomized Controlled Pilot Study.
    Gutiérrez-Repiso C; Hernández-García C; García-Almeida JM; Bellido D; Martín-Núñez GM; Sánchez-Alcoholado L; Alcaide-Torres J; Sajoux I; Tinahones FJ; Moreno-Indias I
    Mol Nutr Food Res; 2019 Oct; 63(19):e1900167. PubMed ID: 31298466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Potential Roles of Very Low Calorie, Very Low Calorie Ketogenic Diets and Very Low Carbohydrate Diets on the Gut Microbiota Composition.
    Rondanelli M; Gasparri C; Peroni G; Faliva MA; Naso M; Perna S; Bazire P; Sajuox I; Maugeri R; Rigon C
    Front Endocrinol (Lausanne); 2021; 12():662591. PubMed ID: 34054731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Firmicutes populations.
    Riva A; Borgo F; Lassandro C; Verduci E; Morace G; Borghi E; Berry D
    Environ Microbiol; 2017 Jan; 19(1):95-105. PubMed ID: 27450202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of a Very-Low-Calorie Ketogenic Diet in the Gut Microbiota Composition in Obesity.
    Zambrano AK; Cadena-Ullauri S; Guevara-Ramírez P; Frias-Toral E; Ruiz-Pozo VA; Paz-Cruz E; Tamayo-Trujillo R; Chapela S; Montalván M; Sarno G; Guerra CV; Simancas-Racines D
    Nutrients; 2023 Jun; 15(12):. PubMed ID: 37375632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a 2-Month Very Low-Calorie Ketogenic Diet (VLCKD) Compared to a Standard Low-Calorie Diet in Reducing Visceral and Liver Fat Accumulation in Patients With Obesity.
    Cunha GM; Guzman G; Correa De Mello LL; Trein B; Spina L; Bussade I; Marques Prata J; Sajoux I; Countinho W
    Front Endocrinol (Lausanne); 2020; 11():607. PubMed ID: 33042004
    [No Abstract]   [Full Text] [Related]  

  • 9. Short-Chain Fatty Acids-A Product of the Microbiome and Its Participation in Two-Way Communication on the Microbiome-Host Mammal Line.
    Lange O; Proczko-Stepaniak M; Mika A
    Curr Obes Rep; 2023 Jun; 12(2):108-126. PubMed ID: 37208544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gut microbiome as possible mediator of the beneficial effects of very low calorie ketogenic diet on type 2 diabetes and obesity: a narrative review.
    Defeudis G; Rossini M; Khazrai YM; Pipicelli AMV; Brucoli G; Veneziano M; Strollo F; ; Bellia A; Bitterman O; Lauro D; Mora D; Santarelli E
    Eat Weight Disord; 2022 Oct; 27(7):2339-2346. PubMed ID: 35773554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health.
    Nogal A; Valdes AM; Menni C
    Gut Microbes; 2021; 13(1):1-24. PubMed ID: 33764858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xiexin Tang ameliorates dyslipidemia in high-fat diet-induced obese rats via elevating gut microbiota-derived short chain fatty acids production and adjusting energy metabolism.
    Xiao S; Zhang Z; Chen M; Zou J; Jiang S; Qian D; Duan J
    J Ethnopharmacol; 2019 Sep; 241():112032. PubMed ID: 31220598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity.
    Remely M; Aumueller E; Merold C; Dworzak S; Hippe B; Zanner J; Pointner A; Brath H; Haslberger AG
    Gene; 2014 Mar; 537(1):85-92. PubMed ID: 24325907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis.
    Castellana M; Conte E; Cignarelli A; Perrini S; Giustina A; Giovanella L; Giorgino F; Trimboli P
    Rev Endocr Metab Disord; 2020 Mar; 21(1):5-16. PubMed ID: 31705259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-Term Physiological Effects of a Very Low-Calorie Ketogenic Diet: Effects on Adiponectin Levels and Inflammatory States.
    Monda V; Polito R; Lovino A; Finaldi A; Valenzano A; Nigro E; Corso G; Sessa F; Asmundo A; Nunno ND; Cibelli G; Messina G
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32370212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota and BMI throughout childhood: the role of firmicutes, bacteroidetes, and short-chain fatty acid producers.
    Houtman TA; Eckermann HA; Smidt H; de Weerth C
    Sci Rep; 2022 Feb; 12(1):3140. PubMed ID: 35210542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity and Obesity-Related Thyroid Dysfunction: Any Potential Role for the Very Low-Calorie Ketogenic Diet (VLCKD)?
    Chapela SP; Simancas-Racines A; Ceriani F; Martinuzzi ALN; Russo MP; Zambrano AK; Simancas-Racines D; Verde L; Muscogiuri G; Katsanos CS; Frias-Toral E; Barrea L
    Curr Nutr Rep; 2024 Jun; 13(2):194-213. PubMed ID: 38526760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erchen Decoction alleviates obesity-related hepatic steatosis via modulating gut microbiota-drived butyric acid contents and promoting fatty acid β-oxidation.
    Zhang L; Chen N; Zhan L; Bi T; Zhou W; Zhang L; Zhu L
    J Ethnopharmacol; 2023 Dec; 317():116811. PubMed ID: 37336336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors.
    de la Cuesta-Zuluaga J; Mueller NT; Álvarez-Quintero R; Velásquez-Mejía EP; Sierra JA; Corrales-Agudelo V; Carmona JA; Abad JM; Escobar JS
    Nutrients; 2018 Dec; 11(1):. PubMed ID: 30591685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota-Derived Short-Chain Fatty Acids Facilitate Microbiota:Host Cross talk and Modulate Obesity and Hypertension.
    Overby HB; Ferguson JF
    Curr Hypertens Rep; 2021 Feb; 23(2):8. PubMed ID: 33537923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.